# Kyverna Therapeutics, Inc. — Form D

Kyverna Therapeutics, Inc. of EMERYVILLE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-11-07. The offering totals $152.0M, of which $152.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2023-11-07
- Form: D
- Accession: 0001994702-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $152.0M
- Amount sold: $152.0M
- Investors: 24
- Date of first sale: 2021-11-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-496597

## Issuer

- Name: Kyverna Therapeutics, Inc.
- CIK: 0001994702
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 5980 HORTON STREET, EMERYVILLE, CA, 94608
- Phone: 5106268331

## Officers, directors & promoters (12)

| Name | Role | Location |
| --- | --- | --- |
| Ian Clark | Director | SOUTH SAN FRANCISCO, CA |
| Fred Cohen | Director | AUSTIN, TX |
| Brian Kotzin | Director | Emeryville, CA |
| Steve Liapis | Director | Cambridge, MA |
| Peter Maag | Director | Emeryville, CA |
| Beth Spiegelman | Director | Emeryville, CA |
| Dan Spiegelman | Director | Emeryville, CA |
| Dominic Borie | Executive Officer | Boston, MA |
| James Chung | Executive Officer | New York City, NY |
| Ryan Jones | Executive Officer | Bartlesville, OK |
| Peter Maag | Executive Officer | Emeryville, CA |
| Karen Walker | Executive Officer | New York, NY |

## More

- [CIK 1994702 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1994702&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001994702-23-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.